All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2025-P-3287
Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form for the reasons set forth below and in the Mifepristone Multistate Citizen Petition (FDA-2025-P-1576)
Documents
57
Comments
16
Description
OPEN
Key Dates
Comment Period OpensAug 26, 2025
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
16
Keywords
CDER
Citizen Petition
Attorney General of Washington, et. al.
remove the Mifepristone REMS Program
including but not limited to the
Prescriber Certification, Pharmacy Certification
Patient Agreement form for the reasons
set forth below and in the Mifepristone
Data from Regulations.gov